FSANZ proposes amendments to compositional requirements for infant medical products

FSANZ Proposal P1065: Ensuring Precision in Infant Nutritional Standards

As leading contract manufacturers in the supplement industry, we understand the critical importance of regulatory precision, especially when it concerns vulnerable populations. Food Standards Australia New Zealand (FSANZ) has recently released Proposal P1065, signalling an intent to amend the Australia New Zealand Food Standards Code.

This proposal primarily addresses compositional fat requirements for 'Special Medical Purpose Products for infants'. It appears these specific requirements, though previously approved under Proposal P1028, were inadvertently omitted from the subsequent Code amendments. From a formulation standpoint, rectifying such omissions is vital. For manufacturers like us, who may produce specialised infant nutritional products, clarity on exact compositional mandates, particularly for critical macronutrients like fat, is paramount for product safety, efficacy, and regulatory compliance.

Beyond this significant amendment, FSANZ also aims to implement various minor revisions. These include what they describe as 'correction of typographical errors, omissions, inconsistencies, formatting issues and updating references'. While seemingly small, these adjustments are crucial for maintaining the integrity and clarity of the entire Food Standards Code. An ambiguous or inconsistent clause can lead to considerable interpretations issues for brand owners and manufacturers, potentially affecting everything from raw material sourcing to labelling requirements.

Implications for the Manufacturing and Brand Landscape

The call for submissions for Proposal P1065 closes on 4 December 2025. This consultation period provides an essential opportunity for industry stakeholders, including contract manufacturers and brand owners, to provide feedback. Engaging with regulatory bodies like FSANZ during these windows is vital to ensure that proposed changes are practical, achievable, and supportive of both product innovation and consumer safety.

Brand owners should note that even 'minor' amendments can have ripple effects throughout the product development and manufacturing lifecycle. Changes in reference standards, for instance, could necessitate updates to ingredient specifications or analytical testing protocols.

For contract manufacturers, staying abreast of such amendments is fundamental to our service offering. It enables us to guide our clients effectively, ensuring their products meet the latest regulatory requirements in Australia and New Zealand. This proactive approach helps prevent costly delays, product recalls, and reputational damage. It also highlights the need for robust quality management systems and agile production capabilities that can adapt swiftly to evolving regulatory landscapes.

Ultimately, these ongoing revisions by FSANZ reinforce the dynamic nature of food and supplement regulation. They underscore the continuous effort required by all parties in the supply chain to uphold the highest standards for consumer protection, particularly for sensitive categories such as infant nutrition.

Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.